Elanco Animal Health (ELAN) Cash Flow Statement
A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
Total Cash From Operating Activities Chart for Elanco Animal Health
Elanco Animal Health (ELAN) operating cash flow for FY2025 was USD 560.0M, a 3.5% change from FY2024. Elanco Animal Health's operating cash flow grew from USD 6.6M in 2015 to USD 560.0M in 2025 (8384.8% over 10 years). Operating cash flow compound annual growth rate: 10-year CAGR of 55.9%.
Total Cash From Operating Activities (US Dollars)
R&D as % of Revenue
Key Stats
- Market Cap
- $11.17B
- Implied Share Price
- $22.36
- Enterprise Value
- $14.66B
- Revenue (TTM)
- $5.02B
- EBITDA
- $1.01B
- Profit Margin
- -3.96%
- Trailing P/E
- —
- Forward P/E
- 17.36
- Price/Book (MRQ)
- 1.71
- Price/Sales (TTM)
- 2.23
- EV/EBITDA
- 18.92
- EV/Revenue
- 2.92
- Dividend Yield
- —
- Book Value
- $13.19
- Free Cash Flow (FY2025)
- $284.00M
- Free Cash Flow Yield
- 2.54%
Snapshot as of 7th October 2026 — not point-in-time controlled, may lag the live market by a few days.